World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01404468
Date of registration: 21/07/2011
Prospective Registration: No
Primary sponsor: Shiraz University of Medical Sciences
Public title: The Phonophoresis of Lidocaine Gel and Its Effect on Sensory Blockage
Scientific title: Effect of Lidocaine Phonophoresis on Sensory Blockade: Pulsed or Continuous Mode of Therapeutic Ultrasound?
Date of first enrolment: March 2006
Target sample size: 93
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01404468
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science  
Phase:  Phase 0
Countries of recruitment
Iran, Islamic Republic of
Contacts
Name:     samaneh ebrahimi, PhD student
Address: 
Telephone:
Email:
Affiliation:  PhD student in shiraz university of medical sciences
Key inclusion & exclusion criteria

Inclusion Criteria:

- Men and women aged 18 to 25 years

Exclusion Criteria:

- individuals who had a disease that could affect the experiment, such as systemic
disease,impairment of the sensory system(e.g.neuropathy,diabetes),cardiovascular
disorders(e.g. increased blood pressure),pain due to an injury to the upper
extremity,tumours,malignant and precancerous tissue,acute infection and broken skin
in the area; and individuals taking medication to relieve disease symptoms were
excluded



Age minimum: 18 Years
Age maximum: 28 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Impairment, Light Touch Sensation
Pain
Intervention(s)
Device: continuous ultrasound device with lidocaine
Other: off device
Device: pulsed ultrasound device with lidocaine
Primary Outcome(s)
Two-point discrimination,touch and maximum pain thresholds [Time Frame: imediately after finishing the application of ultrasound (5 minutes after intervention)]
Secondary Outcome(s)
Secondary ID(s)
84-7.33
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history